{
  "format": "listen-step-protocol@1",
  "kind": "module",
  "name": "Myocet-type non-PEGylated liposomal doxorubicin",
  "tags": [
    "Liposome",
    "Literature recipe"
  ],
  "steps": [],
  "labItems": [
    {
      "id": "component-myocet-nonpegylated-liposomal-doxorubicin",
      "kind": "recipe",
      "afterStep": 0,
      "snapshot": {
        "id": "literature-myocet-nonpegylated-liposomal-doxorubicin",
        "kind": "recipe",
        "name": "Myocet-type non-PEGylated liposomal doxorubicin",
        "category": "Liposome",
        "tags": [
          "Liposome",
          "Literature recipe"
        ],
        "steps": [],
        "materials": [
          {
            "name": "Egg phosphatidylcholine (EPC)",
            "detail": "55 mol%"
          },
          {
            "name": "Cholesterol",
            "detail": "45 mol%"
          },
          {
            "name": "Citrate buffer",
            "detail": "300 mM, pH 4.0 for blank liposomes"
          },
          {
            "name": "Sodium carbonate",
            "detail": "Adjust external pH to approximately 7.3"
          },
          {
            "name": "Doxorubicin",
            "detail": "Drug-to-lipid ratio about 0.27 in the reviewed formulation"
          }
        ],
        "tables": [
          {
            "id": "membrane",
            "name": "Non-PEGylated lipid membrane",
            "header": [
              "Component",
              "Molar percentage",
              "Role"
            ],
            "rows": [
              [
                "EPC",
                "55 mol%",
                "Acidic egg phosphatidylcholine membrane"
              ],
              [
                "Cholesterol",
                "45 mol%",
                "Membrane composition"
              ]
            ]
          },
          {
            "id": "active-loading",
            "name": "Active-loading context",
            "header": [
              "Parameter",
              "Value",
              "Purpose"
            ],
            "rows": [
              [
                "Internal citrate buffer",
                "300 mM, pH 4.0",
                "Blank-liposome hydration"
              ],
              [
                "External pH",
                "Approximately 7.3 with sodium carbonate",
                "Create loading conditions"
              ],
              [
                "Drug-to-lipid ratio",
                "About 0.27",
                "Reviewed formulation"
              ],
              [
                "Diameter",
                "150–250 nm",
                "Reviewed formulation context"
              ]
            ]
          }
        ],
        "tableChoices": {},
        "author": "Listen Step",
        "origin": {
          "type": "curated-literature",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5489929/",
          "reviewedAt": "2026-11-09"
        },
        "source": {
          "citation": "Bulbake U et al. Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics 9, 12 (2017).",
          "doi": "10.3390/pharmaceutics9020012",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5489929/",
          "locator": "Table 1, Myocet; Section 3.1.4, composition and active loading"
        },
        "review": {
          "status": "source-values-checked",
          "reviewedAt": "2026-11-09",
          "scope": "Literature composition only, not a clinical manufacturing or administration protocol. Product indication is retained only as formulation context."
        },
        "createdAt": 1794182400000,
        "updatedAt": 1794182400000
      }
    }
  ],
  "materials": [
    {
      "name": "Egg phosphatidylcholine (EPC)",
      "detail": "55 mol%"
    },
    {
      "name": "Cholesterol",
      "detail": "45 mol%"
    },
    {
      "name": "Citrate buffer",
      "detail": "300 mM, pH 4.0 for blank liposomes"
    },
    {
      "name": "Sodium carbonate",
      "detail": "Adjust external pH to approximately 7.3"
    },
    {
      "name": "Doxorubicin",
      "detail": "Drug-to-lipid ratio about 0.27 in the reviewed formulation"
    }
  ],
  "source": {
    "citation": "Bulbake U et al. Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics 9, 12 (2017).",
    "doi": "10.3390/pharmaceutics9020012",
    "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5489929/",
    "locator": "Table 1, Myocet; Section 3.1.4, composition and active loading"
  },
  "review": {
    "status": "source-values-checked",
    "reviewedAt": "2026-11-09"
  }
}
